Magnetic Stimulation Therapy for Treating Vascular Depression

Completed · Phase 3 · Has a placebo group

Conditions studied: Depressive Disorder, Depression

In brief

This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).

Key facts

Study ID

NCT00044798

Run by

University of Iowa

People needed

132

Starts

2001-09-01

Expected to finish

2008-08-01

Last updated by the study team

2013-09-27

Who can join

Age: 51 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• DSM-IV diagnosis of unipolar major or minor depressive disorder
• Hamilton Depression Rating Scale score of at least 18
• Depression that is associated with cerebrovascular disease
• Failed at least 1 treatment for vascular depression

Where it is running

• University of Iowa Health Care — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.